Sandu Pharmaceuticals Complete Financial Statements

SANDUPHQ • Review detailed financials to uncover trends, confirm thesis & journal trades
5 Years of Data
2025 - 2021

Complete Financial Data Export

Export complete financial statements for Sandu Pharmaceuticals (SANDUPHQ). Downloads include all available records across all periods. For market performance, see the SANDUPHQ stock price today .

Profitability Ratios

EBITDA Margin 7.14% 2025 data
Operating Margin 3.00% 2025 data

Balance Sheet Ratios

Current Ratio 13.00 2025 data
Debt to Equity 1.33 2025 data
Equity Ratio 75.00% 2025 data
Asset Turnover 0.25 2025 data

Year-over-Year Growth Analysis

Comparing Mar 2024 vs Mar 2025
Revenue Growth
-12.5%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
Expense Growth
-6.7%
Year-over-Year
Assets Growth
+7.7%
Year-over-Year
Equity Growth
+2.4%
Year-over-Year
Liabilities Growth
+7.7%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Mar 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Jun 2021
Revenue 14 18 16 17 18 17 15 18 18 17 12 16 17 18 17
Expenses 14 17 15 17 17 16 15 17 17 16 11 16 16 17 17
EBITDA 1 1 1 0 1 1 1 0 1 1 1 0 1 1 1
Operating Profit Margin % 3.00% 5.00% 4.00% 2.00% 5.00% 5.00% 3.00% 2.00% 3.00% 5.00% 5.00% 2.00% 5.00% 5.00% 4.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 1 1 0 1 1 0 0 0 1 0 0 1 1 1
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 1 1 0 1 1 0 0 0 1 0 0 1 0 0
Earnings Per Share (₹) 0.34 1.95 0.62 0.17 0.57 0.57 0.26 0.11 0.21 0.64 0.34 0.19 0.51 0.57 0.53

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023
ASSETS
Total Assets 56 52 54
Current Assets 26 22 26
Fixed Assets 18 18 17
Capital Work in Progress 0 0 0
Investments 11 10 10
Other Assets 26 24 28
LIABILITIES
Total Liabilities 56 52 54
Current Liabilities 2 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 42 41 39
Share Capital 10 10 10
Reserves & Surplus 32 31 30

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities 1 1 0
Investing Activities 0 -1 1
Financing Activities -1 -1 1
Net Cash Flow 0 -1 1